Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01851369
Title TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

colorectal adenocarcinoma

lung non-small cell carcinoma

granulosa cell tumor

Advanced Solid Tumor


Temozolomide + TRC102

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.